Market Research Logo

Rheumatology Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Rheumatology Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

The report on global rheumatology therapeutics market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global rheumatology therapeutics market to grow with a CAGR of 2.52 % over the period of 2018 - 2024. The study on rheumatology therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024. According to report growing geriatric population and growing prevalence of rheumatic arthritis in the major parts of North America and Europe are likely to drive the growth in the world rheumatic therapeutics market over the forecast period.

The report on rheumatology therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the Global rheumatology therapeutics market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global rheumatology therapeutics market over the period of 2016 – 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research methodology
• Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

• Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include
• Company reports and publications
• Government/institutional publications
• Trade and associations’ journals
• Databases such as WTO, OECD, World Bank, and among others.
• Websites and publications by research agencies

Segments Covered

The global rheumatology therapeutics market ïs segmented on the basis of drug class, disease indication, and distribution channel

Global Rheumatology Therapeutics Market by Drug Class
• Disease Modifying Anti-rheumatic Drugs
• Nonsteroidal Anti-inflammatory Drugs
• Corticosteroids
• Uric Acid Drugs
• Others

Global Rheumatology Therapeutics Market by Disease Indication
• Rheumatoid Arthritis
• Osteoarthritis
• Gout
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Others

Global Rheumatology Therapeutics Market by Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Rheumatology Therapeutics Market by Regions
• North America
• Europe
• Asia-Pacific
• RoW

Companies Profiled
• Takeda Pharmaceutical
• Sanofi
• Genentech, Inc.
• Novartis AG
• Janssen Biotech, Inc.
• Amgen, Inc.
• AbbVie, Inc.
• Pfizer, Inc.
• Bristol-Myers Squibb Company
• Merck & Co., Inc

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of rheumatology therapeutics market.
2. Complete coverage of all the segments in rheumatology therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global rheumatology therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on rheumatology therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the Global rheumatology therapeutics market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Rheumatology Therapeutics Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
3.4 IGR – Growth Matrix Analysis
3.5 Competitive Landscape in the Global Rheumatology Therapeutics Market
4. Global Rheumatology Therapeutics Market by Drug Class 2018 - 2024
4.1 Disease Modifying Anti-rheumatic Drugs
4.2 Nonsteroidal Anti-inflammatory Drugs
4.3 Corticosteroids
4.4 Uric Acid Drugs
4.5 Others
5. Global Rheumatology Therapeutics Market by Disease Indication 2018 - 2024
5.1 Rheumatoid Arthritis
5.2 Osteoarthritis
5.3 Gout
5.4 Psoriatic Arthritis
5.5 Ankylosing Spondylitis
5.6 Others
6. Global Rheumatology Therapeutics Market by Distribution Channel 2018 - 2024
6.1 Hospital Pharmacy
6.2 Retail Pharmacy
6.3 Online Pharmacy
7. Global Rheumatology Therapeutics Market by Regions 2018 - 2024
7.1 North America
7.1.1 North America Rheumatology Therapeutics Market by Drug Class
7.1.2 North America Rheumatology Therapeutics Market by Disease Indication
7.1.3 North America Rheumatology Therapeutics Market by Distribution Channel
7.1.4 North America Rheumatology Therapeutics Market by Country
7.2 Europe
7.2.1 Europe Rheumatology Therapeutics Market by Drug Class
7.2.2 Europe Rheumatology Therapeutics Market by Disease Indication
7.2.3 Europe Rheumatology Therapeutics Market by Distribution Channel
7.2.4 Europe Rheumatology Therapeutics Market by Country
7.3 Asia-Pacific
7.3.1 Asia-Pacific Rheumatology Therapeutics Market by Drug Class
7.3.2 Asia-Pacific Rheumatology Therapeutics Market by Disease Indication
7.3.3 Asia-Pacific Rheumatology Therapeutics Market by Distribution Channel
7.3.4 Asia-Pacific Rheumatology Therapeutics Market by Country
7.4 RoW
7.4.1 RoW Rheumatology Therapeutics Market by Drug Class
7.4.2 RoW Rheumatology Therapeutics Market by Disease Indication
7.4.3 RoW Rheumatology Therapeutics Market by Distribution Channel
7.4.4 RoW Rheumatology Therapeutics Market by Sub-region
8. Companies Covered
8.1 Takeda Pharmaceutical
8.2 Sanofi
8.3 Genentech, Inc.
8.4 Novartis AG
8.5 Janssen Biotech, Inc.
8.6 Amgen, Inc.
8.7 AbbVie, Inc.
8.8 Pfizer, Inc.
8.9 Bristol-Myers Squibb Company
8.10 Merck & Co., Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report